
Idea Pharma boosts UK and US teams
pharmafile | February 21, 2011 | Appointment | Sales and Marketing |Â Â IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketingÂ
Idea Pharma has made new appointments to its UK- and US-based teams
Michael Morgan-Curran (pictured) joins the consultancy’s core strategic delivery team in the UK, where he will be tasked with shaping and leading new approaches to help clients make better decisions for products across a variety of therapeutic areas.
Michael has 22 years’ experience working in the pharmaceutical and consultancy industry, including a stint with AstraZeneca where he focused on innovation.
Idea has also appointed Jeff Frick as a principal strategist to the US arm of its business, where he will have a ‘commercial lead’ role to further expand the company’s existing and future portfolio.
Jeff has over 25 years’ global experience in the healthcare, pharmaceutical, biotechnology and medical device industries.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






